Verge Genomics Stock
Drug Discovery
Sign up today and learn more about Verge Genomics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Verge Genomics Stock
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Investors
ALS Investment Fund
Basis Set Ventures
Draper Associates
Thumbtack, Webflow, Standard Cognition, Tempo Automation, Goldbelly, Aerospike, Samba TV, Indiegogo, Verge Genomics, CryptoMove
Great Oaks Venture Capital
Acorns, Bolt Financial, Workrise, Collective Health, Course Hero, SingleStore, Virta Health, Human Interest, Maven Clinic, Petal
LifeForce Capital
Cityblock Health, HeartFlow, One Medical, Clover Health, Grand Rounds Health, Vineti, Verge Genomics
OS Fund
Pivot Bio, Emulate, Tempo Automation, Human Longevity, Verge Genomics, Elysium Health, uBiome, 3T Biosciences
Threshold
Zymergen, BetterUp, Talkdesk, Remitly, Divvy Homes, Prosper Marketplace, CircleCI, Viz, d.light design, Mythic
WuXi AppTec
Funding History
| June 2018 | $370K |
|---|---|
| June 2018 | $150K |
| June 2018 | $100K |
| June 2018 | $3.4M |
| June 2018 | $4.5M |
| June 2018 | $28.2M |
Management
Co-Founder & Chief Executive Officer
Alice Zhang
Chief Business Officer
Jane Rhodes
Press
businessinsider - Aug, 17 2023
The CEO of Verge Genomics shares how she's overcome gender and age biases in biotech by showing people 'there can be a new way of doing things'biospace - Dec, 6 2022
Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officerbiospace - Nov, 22 2022
Alice Zhang, CEO & Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discoverybiospace - Nov, 21 2022
Verge Genomics to Present at Upcoming Investor Conferences in Novemberbiospace - Oct, 17 2022
Verge Genomics Appoints John Applegate as Chief Financial Officerbiospace - Dec, 23 2021
Verge Genomics Secures $98 Million in New Financingwsj - Jul, 10 2021
VC Daily: Eli Lilly, Verge Genomics Join Forces to Tackle ALSbioworld - Jul, 9 2021
Lilly taps Verge Genomics AI-driven discovery platform in new multiyear dealow - Jul, 9 2021
Lilly, Verge Genomics to Work on ALS Treatmentsbioworld - Jul, 8 2021
Host genetics study identifies COVID-19 risk factorssplento - May, 25 2021
Top 25 healthcare technology startups Transforming the world of healthcarebit - Sep, 16 2020
Osmind wants to refine drug therapies for mental health treatmentsPR Newswire - Jun, 27 2020
Verge Genomics' CEO Alice Zhang Named to MIT Technology Review's 2018 Innovators Under 35 ListLegalReader - Apr, 22 2020
10 Digital Health Startups You Need to Watch in 2020nanalyze - Apr, 10 2019
When Will There Be a Cure for Parkinson’s Disease?businesswire - Jul, 20 2018
Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discoveryxconomy - Jul, 17 2018
Verge Genomics Nabs $32M For Computation-Heavy Neuro Drug Discoveryfiercebiotech - Jul, 17 2018
Verge Genomics gathers $32M to trial its AI-built neuroscience drugsdealstreetasia - Jul, 17 2018
China Digest: Sinovation backs $30m Series B in 7Net; Wuxi invests in Verge Genomicsfinsmes - Jul, 17 2018
Artificial Intelligence-Driven Drug Discovery Company Verge Genomics Raises $32MFierceBiotech - Jul, 16 2018
Verge Genomics gathers $32M to trial its AI-built neuroscience drugsprnewswire - May, 21 2018
Verge Genomics Announces Landmark Effort to Generate Field's First Single Cell Data from Patients with Parkinson's Diseaseblog - Dec, 16 2017
Hard Tech Startupsnanalyze - Apr, 26 2017
9 Computational Drug Discovery Startups Using AIstrictlyvc - Feb, 24 2017
StrictlyVC: November 3, 2015blog - Jan, 17 2017
Affordable Carexconomy - Jul, 8 2016
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & Morexconomy - Jul, 6 2016
No PhD, “No Fear”: Alice Zhang, 27, Aims Software At Neuro Diseasessiliconbeat - Apr, 14 2016
End of the IPO? Tim Draper thinks socbinsights - Jan, 29 2016
Seed Funding To US Healthcare Startups Breaks $100M Mark For Second Year In A Rowblog - Nov, 8 2015
YC Digest - October 24-30TechCrunch - Nov, 4 2015
Verge Genomics, On A Quest To Cure Neurodegenerative Disorders, Picks Up $4M Seedfinsmes - Nov, 4 2015
Verge Genomics Closes $4M in Seed Financingxconomy - Nov, 4 2015
Even With New Crowdfunding Rules, No Easy Path Forward For Biotechspehub - Nov, 4 2015
Verge Genomics collects $4 mln seedTechCrunch - Aug, 19 2015
The 50 Startups That Launched At Y Combinator Summer 2015 Demo Day 1TechCrunch - Jul, 21 2015
Verge Genomics Wants To Cure Neurodegenerative Diseases Through Advanced AlgorithmsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
